The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...

Iran's Jamming of Starlink uses military-grade electronic warfare (EW) tools, likely imported from China and Russia deployed ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...

BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, ...

Practice CBSE Class 12 Physics Top 50 MCQs with Answers based on the latest syllabus and exam pattern. Prepare effectively ...

Nigeria’s satellite broadband market is entering a new competitive phase after NCC granted Amazon’s Project Kuiper a 7-year ...

BHPian BlackBeard recently shared this with other enthusiasts:Hello folks. Since many enthusiasts here are keen on knowing ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

A recent study published in Computers in Human Behavior suggests that individuals who excessively use their smartphones ...

Curious to find out all the requirements for the different phases of the 2nd Expedition Project? Here is what players need to ...